161 related articles for article (PubMed ID: 28927823)
1. T cell therapies for human polyomavirus diseases.
Davies SI; Muranski P
Cytotherapy; 2017 Nov; 19(11):1302-1316. PubMed ID: 28927823
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.
Mani J; Jin N; Schmitt M
Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303
[TBL] [Abstract][Full Text] [Related]
3. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
4. Human polyomaviruses in disease and cancer.
Dalianis T; Hirsch HH
Virology; 2013 Mar; 437(2):63-72. PubMed ID: 23357733
[TBL] [Abstract][Full Text] [Related]
5. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
6. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy.
Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS
Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645
[TBL] [Abstract][Full Text] [Related]
7. Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.
Saribas AS; Coric P; Bouaziz S; Safak M
J Cell Physiol; 2019 Jun; 234(6):8295-8315. PubMed ID: 30390301
[TBL] [Abstract][Full Text] [Related]
8. The role of polyomaviruses in human disease.
Jiang M; Abend JR; Johnson SF; Imperiale MJ
Virology; 2009 Feb; 384(2):266-73. PubMed ID: 18995875
[TBL] [Abstract][Full Text] [Related]
9. Post-transplantation polyomavirus infections.
Boubenider S; Hiesse C; Marchand S; Hafi A; Kriaa F; Charpentier B
J Nephrol; 1999; 12(1):24-9. PubMed ID: 10202999
[TBL] [Abstract][Full Text] [Related]
10. Adoptive immunotherapy with virus-specific T cells.
Fuji S; Kapp M; Grigoleit GU; Einsele H
Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
[TBL] [Abstract][Full Text] [Related]
11. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.
Ambalathingal GR; Francis RS; Smyth MJ; Smith C; Khanna R
Clin Microbiol Rev; 2017 Apr; 30(2):503-528. PubMed ID: 28298471
[TBL] [Abstract][Full Text] [Related]
12. Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.
Nelson AS; Yalamarthi N; Yong MK; Blyth E
Curr Opin Infect Dis; 2021 Dec; 34(6):627-634. PubMed ID: 34751182
[TBL] [Abstract][Full Text] [Related]
13. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and management of polyomavirus infection in transplant recipients.
Kwak EJ; Vilchez RA; Randhawa P; Shapiro R; Butel JS; Kusne S
Clin Infect Dis; 2002 Nov; 35(9):1081-7. PubMed ID: 12384842
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for polyomaviruses: opportunities and challenges.
Dalianis T
Immunotherapy; 2012 Jun; 4(6):617-28. PubMed ID: 22788129
[TBL] [Abstract][Full Text] [Related]
16. BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation.
Pello OM; Innes AJ; Bradshaw A; Finn SA; Uddin S; Bray E; Olavarria E; Apperley JF; Pavlů J
Eur J Haematol; 2017 Jun; 98(6):632-634. PubMed ID: 28083990
[TBL] [Abstract][Full Text] [Related]
17. The role of sialic acid in human polyomavirus infections.
Gee GV; Dugan AS; Tsomaia N; Mierke DF; Atwood WJ
Glycoconj J; 2006 Feb; 23(1-2):19-26. PubMed ID: 16575519
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic options for the management of human polyomaviruses.
Roskopf J; Trofe J; Stratta RJ; Ahsan N
Adv Exp Med Biol; 2006; 577():228-54. PubMed ID: 16626040
[TBL] [Abstract][Full Text] [Related]
19. Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant.
Sutrave G; Blyth E; Gottlieb DJ
Cytotherapy; 2017 Nov; 19(11):1284-1301. PubMed ID: 28927824
[TBL] [Abstract][Full Text] [Related]
20. Polyomavirus nephropathy: a brief review with special emphasis on clinico-patholgical aspects.
Mihatsch MJ
Prilozi; 2012; 33(2):5-22. PubMed ID: 23425866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
